4 Biotech Stocks With Big Catalysts in September

Two presentations at the World Conference on Lung Cancer will make a big difference for at least four different drugmakers. The biopharmaceutical industry has been exploding, with roughly one new initial public offering every week. There are so many drug developers out there, new and old, that it can be tough to spot the ones…

Is This $5 Billion Biotech IPO a Buy?

10X Genomics is growing revenue at a healthy clip, but a series of patent-infringement suits are hanging over the lab-hardware business. Single-cell analysis took a little while to arrive, but the analytical approach is finally proving its worth in biology labs across the globe. It’s also starting to power considerable growth for companies well-positioned to…

2 Biotech Stocks I Wouldn’t Touch With a Broom

Here’s why shares of these drugmakers have a very slim chance to provide anything but losses. Drug development is a losing game full of highly trained professionals who would rather be lucky than talented at their jobs. This is because experimental new drugs fail so frequently that an entire career without one successful new drug…

A Biotech Set to Dominate the Next 20 Years

Ionis Pharma has some powerful numbers now. But its future opportunities are even more amazing. Investing in growth stocks can feel like a roller-coaster ride. For instance, at the beginning of the year, Ionis Pharmaceuticals (NASDAQ:IONS) was trading at $52 a share. By April, the stock was up to $86 a share. And now it’s back…

Why viruses like Herpes and Zika will need to be reclassified, and its biotech impact

Evolutionary related viruses infecting bacteria and humans adopting one of the newly established protein layouts of icosahedral capsids. Bacillus phage Basilisk (a), herpes simplex virus 1 (b), and bacteriophage lambda (c). Credit: Antoni Luque, San Diego State University and Reidun Twarock, University of York. New research reveals that the way viruses were perceived in terms…

Next Up In China Trade War: Biotech Purge?

Lab technicians at the R&D center of Wuxi Pharmatech in Shanghai. China is gaining on patents, especially in DNA-sequencing drugs and cancer research. Good or bad? Washington thinks bad. Qilai Shen/BLOOMBERG NEWSWell, it’s sort of like technology. If it involves scientific patents, the U.S. has increasingly lost trust in China […]

AI is now being used to shortlist job applicants in the UK — let’s hope it’s not racist

It’s oft-repeated that artificial intelligence will be a danger to our jobs. But perhaps in a not-so-surprising twist, AI is also being increasingly used by companies to hire candidates. According to a report by The Telegraph, AI-based video interviewing software — such as that developed by HireVue — are being leveraged by UK companies for the…

Ben & Jerry’s, Lush, Patagonia among businesses closing Friday for Global Climate Strike

CLOSE New York City’s Education Department announced that students wishing to attend a nationwide climate demonstration will have their absences excused. Buzz60Several businesses have joined the call for climate change and are closing Friday for the Global Climate Strike.Businesses including Ben & Jerry’s, Burton, Lush, Patagonia and SodaStream say they are closing down – for the…